| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $3.84B | $3.61B | $3.11B | $3.25B | $2.88B |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | $398.92M | $271.53M | $232.63M | $194.02M | $195.55M |
| Operating Income | $1.60B | $1.97B | $1.38B | $1.59B | $1.34B |
| Interest Expense | $390.49M | $378.51M | $348.23M | $333.94M | $376.51M |
| Tax Expense | $15.09M | $18.11M | $4.38M | $4.19M | -$9.81M |
| Net Income | $1.18B | $1.57B | $1.02B | $1.22B | $916.29M |
| EPS (basic) | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |